Clinical Course and Treatment of COVID-19 Inpatients in Hospital
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Wissenschaftliches Institut Bethanien e.V
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- convalescence/death
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The study is an epidemiological observational study. It serves to collect data from patients with positive COVID-19 test results who are hospitalized. All data describing the course of the inpatient stay are recorded (Length of stay, course of therapy, medication, X-ray and CT results,ventilation mode and duration, laboratory). Furthermore, anthropometric data and information on COVID-19 symptoms is recorded.
Detailed Description
The aim of this study is to describe the course of disease and the treatment of patients suffering from COVID-19 who are hospitalized and treated as inpatients: 1. Are there common features (previous illnesses, medication, age, BMI, etc.), which may influence the course of disease? 2. Are there therapeutic procedures that have a positive or negative impact on the course of the disease or the length of stay in the intensive care unit/ the duration of ventilation (early/late intubation, CPAP, NIV, ECMO)?
Investigators
Eligibility Criteria
Inclusion Criteria
- •positive COVID-19 test result
- •Age \> 18 years
Exclusion Criteria
- •Age \< 18 years
- •negative COVID-19 test result
- •lack of agreement
- •Any medical, psychological or other condition, that restricts the ability of the person to be informed and to give the consent for voluntary participation in this trial
Outcomes
Primary Outcomes
convalescence/death
Time Frame: through study completion, an average of 2 months
has patient died or has patient recovered
Secondary Outcomes
- length of stay in hospital(through study completion, an average of 2 months)
- length of stay in the intensive care unit(through study completion, an average of 2 months)